Sebastian Ewen asks questions to Anton H. van den Meiracker, the author of "A global approach to hypertension " article published in EuroIntervention Journal Supplement on Resistant Hypertension Treatments, May 2013.
Felix Mahfoud, Course Director, answers the following questions:
- What is unique about the Resistant Hypertension Course?
- Who should participate and why?
- Why promote a hypertension team approach?
Percutaneous renal denervation: new treatment option for resistant hypertension and more?
- Authors: Sebastian Ewen, Christian Ukena, Michael Böhm, Felix Mahfoud
- Reference: Heart 2013;0:1–6.
- Published: 6 March 2013
- Link: Access abstract here
My comment by Sebastian Ewen
Felix Mahfoud, Course Director, talks about the past meeting in Berlin and the ones to come this year
"We are now an official meeting in the EAPCI agenda every year so we continue, we'll have a meeting in February next year again in Berlin and we also settle around the world going to Asia Pacific and we'll have a Resistant Hypertension Course in Singapore in November this year."
Jean Marco invites you to share your comments on the result of the Reduction of Atherothrombosis for Continued Health ( REACH ) registry recently published
« Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis » Eur Heart J (2013) 34 (16): 1204-1214.